Similar articles

• [Anti-meningococcal polysaccharide vaccines].

  Gómez JA, Ferreirós CM, Criado MT. Gómez JA, et al. Enferm Infecc Microbiol Clin. 1997 Aug-Sep;15(7):347-8. Enferm Infecc Microbiol Clin. 1997. PMID: 9410045 Spanish. No abstract available.
• Meningococcal serogroup B vaccine protection trial and follow-up studies in Chile. The Chilean National Committee for Meningococcal Disease.

  Zollinger WD, Boslego J, Moran E, Garcia J, Cruz C, Ruiz S, Brandt B, Martinez M, Arthur J, Underwood P, et al. Zollinger WD, et al. NIPH Ann. 1991 Dec;14(2):211-2; discussion 213. NIPH Ann. 1991. PMID: 1812433 Clinical Trial. No abstract available.
• Review of meningococcal vaccines with emphasis on possible immunoprophylaxis of group B disease.

  Frøholm LO. Frøholm LO. NIPH Ann. 1980 Dec;3(2):67-74. NIPH Ann. 1980. PMID: 6784045 Review. No abstract available.
• Meningococcal strains isolated from teenage patients during the serogroup B vaccination trial in Norway: serotyping, serosubtyping, immunotyping and clonal analysis.

  Frøholm LO, Caugant DA, Holten E, Høiby EA, Rosenqvist E, Wedege E. Frøholm LO, et al. NIPH Ann. 1991 Dec;14(2):139-43; discussion 144-6. NIPH Ann. 1991. PMID: 1812428 Clinical Trial. No abstract available.
• Guidelines for control of meningococcal disease. Laboratory Centre for Disease Control. Canadian Consensus Conference on Meningococcal Disease.

  [No authors listed] [No authors listed] CMAJ. 1994 Jun 1;150(11):1825-39. CMAJ. 1994. PMID: 8199959 Free PMC article. Review. No abstract available.